Stocks and Investing Stocks and Investing
Wed, November 2, 2022
Tue, November 1, 2022
Mon, October 31, 2022
Sun, October 30, 2022

Paul Matteis Maintained (VRTX) at Hold and Held Target at $289 on, Oct 30th, 2022


Published on 2024-10-27 23:45:54 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $289 on, Oct 30th, 2022.

Paul has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 4 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $288 on, Friday, October 28th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $285 on, Friday, October 28th, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022
  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $250 on, Friday, August 5th, 2022


These are the ratings of the 8 analyists that currently disagree with Paul


  • Michael Yee of "Jefferies" Maintained at Strong Buy and Held Target at $340 on, Friday, October 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $335 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $313 on, Friday, October 28th, 2022
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $330 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $327 on, Monday, October 24th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $365 on, Wednesday, July 13th, 2022